Brazil’s main stock market index dropped to a two-month low after President Luiz Inácio Lula da Silva secured a surprise ...

President Trump escalated his attacks on Democratic Senate nominee Abdul El-Sayed, linking him to the Muslim Brotherhood and ...

Consumer confidence tumbled after nationwide protests and a sell-off of government bonds raised questions on the feasibility ...

Japan’s financial authorities are stepping up cybersecurity efforts after the fallout from an attack on a server-hosting ...

EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets.

Like-for-like net revenue in North America fell 1.3%, but the company said it anticipates a rebound from Lysol and North ...

The investment comes as Nvidia and Meta Platforms expand their partnership on the Facebook parent’s artificial-intelligence ...

The Cronos project off Cyprus in the eastern Mediterranean lays the foundation for future drilling in the region, according ...

The luxury sports-car maker said it continued to reap early benefits from a strategic reset.

The Swiss drugmaker cited solid sales growth and productivity gains, even as recent clinical-trial setbacks hit its bottom line in the third quarter.

The bank said quarterly results were supported by growth in banking net interest income and lower expected credit losses.

Oil prices fell as traders weighed fresh regional efforts to ease tensions involving Iran against Houthi attacks on Saudi Arabia and risks to shipping through the Hormuz Strait.